Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Zuber

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Nature Methods|June 10, 2020
Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function allelesGeorg Michlits, Julian Jude, Matthias Hinterndorfer, et al.
Cell Death & Disease|December 12, 2019
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemiaChi Huu Nguyen, Katharina Bauer, Hubert Hackl, et al.
Nature Immunology|February 11, 2014
Stage-specific control of early B cell development by the transcription factor IkarosTanja A Schwickert, Hiromi Tagoh, Sinan Gültekin, et al.
Oncotarget|December 20, 2012
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AMLHarald Herrmann, Katharina Blatt, Junwei Shi, et al.
Oncogene|March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AMLDaniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
Journal of the Royal Society, Interface|December 21, 2021
Agent-based simulations for protecting nursing homes with prevention and vaccination strategiesJana Lasser, Johannes Zuber, Johannes Sorger, et al.
The EMBO Journal|June 25, 2026
Cellular assembly and functional resilience of the mammalian RNA exosomeTsimafei Navalayeu, Nikolaus Beer, Monika Bebjaková, et al.
Blood|October 25, 2014
CDK6 as a key regulator of hematopoietic and leukemic stem cell activationRuth Scheicher, Andrea Hoelbl-Kovacic, Florian Bellutti, et al.
Genes & Development|March 5, 2015
A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growthCorbin E Meacham, Lee N Lawton, Yadira M Soto-Feliciano, et al.
Elife|March 24, 2023
HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylationSara Scinicariello, Adrian Soderholm, Markus Schäfer, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Nature Methods|June 10, 2020
Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function allelesGeorg Michlits, Julian Jude, Matthias Hinterndorfer, et al.
Cell Death & Disease|December 12, 2019
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemiaChi Huu Nguyen, Katharina Bauer, Hubert Hackl, et al.
Nature Immunology|February 11, 2014
Stage-specific control of early B cell development by the transcription factor IkarosTanja A Schwickert, Hiromi Tagoh, Sinan Gültekin, et al.
Oncotarget|December 20, 2012
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AMLHarald Herrmann, Katharina Blatt, Junwei Shi, et al.
Oncogene|March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AMLDaniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
Journal of the Royal Society, Interface|December 21, 2021
Agent-based simulations for protecting nursing homes with prevention and vaccination strategiesJana Lasser, Johannes Zuber, Johannes Sorger, et al.
The EMBO Journal|June 25, 2026
Cellular assembly and functional resilience of the mammalian RNA exosomeTsimafei Navalayeu, Nikolaus Beer, Monika Bebjaková, et al.
Blood|October 25, 2014
CDK6 as a key regulator of hematopoietic and leukemic stem cell activationRuth Scheicher, Andrea Hoelbl-Kovacic, Florian Bellutti, et al.
Genes & Development|March 5, 2015
A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growthCorbin E Meacham, Lee N Lawton, Yadira M Soto-Feliciano, et al.
Elife|March 24, 2023
HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylationSara Scinicariello, Adrian Soderholm, Markus Schäfer, et al.
Pageof 17